HIF1A and neoplasm: In patients with ER-negative tumours, with a high frequency of HIF-1α positive primary tumours (60%), BCD within 10 years was higher compared to ER-positive tumours irrespective of primary tumour HIF-1α status (Supplemental Fig. 2e, f).